Home/Filings/4/0001127602-25-008675
4//SEC Filing

Jones John Jude 4

Accession 0001127602-25-008675

CIK 0000062709other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:01 PM ET

Size

15.9 KB

Accession

0001127602-25-008675

Insider Transaction Report

Form 4
Period: 2025-03-06
Jones John Jude
Chief Marketing Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-03-06$117.53/sh+5,057$594,34913,035 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2025-03-065,0570 total
    Exercise: $117.53Exp: 2031-02-21Common Stock (5,057 underlying)
  • Sale

    Common Stock

    2025-03-06$235.37/sh4,743$1,116,3627,978 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2025-03-064,7430 total
    Exercise: $118.86Exp: 2030-02-18Common Stock (4,743 underlying)
  • Exercise/Conversion

    Common Stock

    2025-03-06$118.86/sh+4,743$563,77712,721 total
  • Sale

    Common Stock

    2025-03-06$234.84/sh5,057$1,187,5847,978 total
  • Sale

    Common Stock

    2025-03-06$235.60/sh1,024$241,2607,978 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,745.077
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $234.790 to $235.050. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
  • [F2]These options were granted on February 19, 2020 and vested in four equal annual installments on February 19th of 2021, 2022, 2023 and 2024
  • [F3]These options were granted on February 22, 2021 and vested in four equal annual installments on February 22nd of 2022, 2023, 2024 and 2025.

Issuer

MARSH & MCLENNAN COMPANIES, INC.

CIK 0000062709

Entity typeother

Related Parties

1
  • filerCIK 0001959460

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:01 PM ET
Size
15.9 KB